FDA Limits Use of Janssen COVID-19 Vaccine to Certain Individuals

Published: 05/05/2022

  • Food and Drug Administration
Relevant To:
  • All Healthcare Organizations

Today, the U.S. Food and Drug Administration (FDA) has limited the authorized use of the Janssen COVID-19 Vaccine to individuals 18 years of age and older for whom other authorized or approved COVID-19 vaccines are not accessible or clinically appropriate, and to individuals 18 years of age and older who elect to receive the Janssen COVID-19 Vaccine because they would otherwise not receive a COVID-19 vaccine.

Key Points:

  • After conducting an updated analysis, evaluation and investigation

Sign Up for Free Trial